Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks.

Xiaofan Chen,Yanan Fan,Chong-Wen Si,Yanyan Yu,Jia Shang,Zujiang Yu,Qing Mao,Qing Xie,Wei Zhao,Jun Li,Zhiliang Gao,Shanming Wu,Hong Tang,Jun Cheng,Xinyue Chen,Wenhong Zhang,Hao Wang,Zhong-Nan Xu,Ling Wang,Jun Dai,Jing-hang Xu

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks.

2021

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks

Keywords:

Medicine
Internal medicine
Randomized controlled trial
Tenofovir
Clinical trial
double blind
chronic hepatitis
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations